Financial results - EMBRYOMED SRL

Financial Summary - Embryomed Srl
Unique identification code: 33834495
Registration number: J23/3407/2014
Nace: 8622
Sales - Ron
109.086
Net Profit - Ron
78.352
Employees
1
Open Account
Company Embryomed Srl with Fiscal Code 33834495 recorded a turnover of 2024 of 109.086, with a net profit of 78.352 and having an average number of employees of 1. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Embryomed Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 21.119 27.372 36.460 40.347 39.542 68.506 91.594 94.120 84.456 109.086
Total Income - EUR 21.119 27.372 36.460 40.347 39.542 68.506 91.594 94.120 84.456 109.086
Total Expenses - EUR 9.877 37.504 26.589 33.846 30.979 30.147 31.687 33.489 39.708 27.470
Gross Profit/Loss - EUR 11.243 -10.132 9.870 6.502 8.563 38.359 59.907 60.631 44.749 81.616
Net Profit/Loss - EUR 10.609 -10.680 7.187 6.098 8.168 37.674 59.105 59.830 43.946 78.352
Employees 1 1 1 0 1 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 29.9%, from 84.456 euro in the year 2023, to 109.086 euro in 2024. The Net Profit increased by 34.651 euro, from 43.946 euro in 2023, to 78.352 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Embryomed Srl

Rating financiar

Financial Rating -
EMBRYOMED SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Embryomed Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Embryomed Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Embryomed Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Embryomed Srl - CUI 33834495

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 107 31.003 30.428 33.200 27.827 21.878 17.300 10.080 8.799 9.663
Current Assets 12.893 4.618 5.421 4.511 7.010 54.841 109.408 147.598 137.032 88.775
Inventories 0 0 0 1.530 32 686 671 673 0 0
Receivables 1.339 2.004 4.460 1.844 1.808 6.586 5.004 1.436 1.492 79.216
Cash 11.554 2.615 961 1.137 5.170 47.569 103.732 145.489 135.540 9.559
Shareholders Funds 12.235 1.430 8.593 14.534 22.420 37.724 95.992 121.191 103.099 78.396
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 766 34.191 27.256 23.176 12.417 38.995 30.716 36.487 42.731 20.043
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 88.775 euro in 2024 which includes Inventories of 0 euro, Receivables of 79.216 euro and cash availability of 9.559 euro.
The company's Equity was valued at 78.396 euro, while total Liabilities amounted to 20.043 euro. Equity decreased by -24.127 euro, from 103.099 euro in 2023, to 78.396 in 2024.

Risk Reports Prices

Reviews - Embryomed Srl

Comments - Embryomed Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.